David Bailey Biography and Net Worth

President & CEO of OrthoPediatrics

David (Dave) Bailey was appointed by the Board of Directors to serve as the Company’s President and CEO effective June 1, 2021. Dave also serves as a Director on the Board for OrthoPediatrics. He joined OrthoPediatrics in 2007 and has spent most of his career helping build the company from its early start-up days, to a publicly traded company. During his tenure at OP, David has held multiple leadership positions of increasing responsibility, including Domestic and International Sales, Operations and oversight of the Trauma & Deformity Correction and Scoliosis business units. As an early employee in the Company’s life cycle, Dave was instrumental in setting the strategic agenda for OP, raising start-up capital, championing new product development, and establishing a global distribution network. Prior to joining OP Dave worked as a Sales Representative and Independent Distributor for Smith & Nephew Orthopaedics. He attended Purdue University in Lafayette and holds a Bachelor of Science in Sales and Sales Management. He has continued his education at the Harvard Business School, where in 2020, he completed the Professional Leadership Development program.

What is David R. Bailey's net worth?: The estimated net worth of David R. Bailey is at least $7.02 million as of March 18th, 2025. Mr. Bailey owns 319,155 shares of OrthoPediatrics stock worth more than $7,021,410 as of July 16th. This net worth approximation does not reflect any other assets that Mr. Bailey may own. Additionally, Mr. Bailey receives a salary of $588,470.00 as President & CEO at OrthoPediatrics. Learn More about David R. Bailey's net worth.
How old is David R. Bailey?: Mr. Bailey is currently 45 years old. There are 6 older executives and no younger executives at OrthoPediatrics. Learn More on David R. Bailey's age.
What is David R. Bailey's salary?: As the President & CEO of OrthoPediatrics Corp., Mr. Bailey earns $588,470.00 per year. Learn More on David R. Bailey's salary.
How do I contact David R. Bailey?: The corporate mailing address for Mr. Bailey and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on David R. Bailey's contact information.
Has David R. Bailey been buying or selling shares of OrthoPediatrics?: David R. Bailey has not been actively trading shares of OrthoPediatrics in the last ninety days. Most recently, David R. Bailey sold 6,620 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a transaction totalling $164,573.20. Following the completion of the sale, the chief executive officer now directly owns 319,155 shares of the company's stock, valued at $7,934,193.30. Learn More on David R. Bailey's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes David Bailey (President & CEO), Bernei Berry, III (Director), Stephen Burns (Director), Daniel Gerritzen (Executive Vice President (Legal) & General Counsel), Joseph Hauser (President of Trauma and Deformity Correction), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 5 times. They sold a total of 33,732 shares worth more than $882,977.52. The most recent insider tranaction occured on March, 18th when General Counsel Daniel J Gerritzen sold 5,310 shares worth more than $132,006.60. Insiders at OrthoPediatrics own 31.8% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 3/18/2025.

David R. Bailey Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2025	Sell	6,620	$24.86	$164,573.20	319,155
3/11/2024	Sell	3,213	$27.59	$88,646.67	139,384
3/6/2023	Sell	4,052	$44.40	$179,908.80	100,453
3/2/2022	Sell	4,078	$58.10	$236,931.80
3/1/2021	Sell	4,769	$55.84	$266,300.96	88,373
12/13/2019	Sell	15,000	$34.31	$514,650.00
4/13/2018	Sell	30,231	$17.92	$541,739.52

David R. Bailey Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $22.00

$21.47

$22.37

50 Day Range

MA: $21.58

$19.96

$23.27

2 Week Range

Now: $22.00

$19.52

$35.99

Volume

116,508 shs

Average Volume

198,039 shs

Market Capitalization

$534.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

David Bailey Biography and Net Worth

What is David R. Bailey's net worth?

How old is David R. Bailey?

What is David R. Bailey's salary?

How do I contact David R. Bailey?

Has David R. Bailey been buying or selling shares of OrthoPediatrics?

Who are OrthoPediatrics' active insiders?

Are insiders buying or selling shares of OrthoPediatrics?